Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11890316 Oral octreotide therapy and contraceptive methods

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ruth Engle Stevens0

Asi Haviv0

Jennings Ray Dawkins0

Date of Patent

February 6, 2024

0

Patent Application Number

174708360

Date Filed

September 9, 2021

0

Patent Citations

US Patent 7217431 Controlled agglomeration

0

US Patent 7288520 Cyclosporin compositions

0

US Patent 7411039 GLP-2 compounds, formulations, and uses thereof

0

US Patent 7759312 Delivery of dry formulations of octreotide

0

US Patent 8133863 Stabilizing alkylglycoside compositions and methods thereof

0

US Patent 8241670 Compositions capable of facilitating penetration across a biological barrier

0

US Patent 8329198 Pharmaceutical compositions and related methods of delivery

0

US Patent 8535695 Pharmaceutical compositions and related methods of delivery

0

...

Patent Primary Examiner

Marcela M Cordero Garcia

0

CPC Code

0

0

0

0

0

0

Patent abstract

This invention relates to methods of administering oral octreotide therapy to a female subject relating to avoidance of combined oral contraceptives or use of a back-up method for contraception.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11890316 Oral octreotide therapy and contraceptive methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool